Abcell-bio Secures CIR Agreement from French Ministry: Offering Enhanced Access to Cord Blood Cells and Tax Benefits for R&D Partners

Abcell-bio arose from the will to accompany research by facilitating the access to primary resources which are difficult to get, especially cells from cord blood.

With a strong and unique network of French maternities and a robust production process, Abcell-bio also develops a Research & Development activity to face the challenges of the upcoming research. To that extent, Abcell-bio has obtained the CIR agreement (Crédit d’Impôt Recherche; Research Tax Credit) from the French Ministry of Education, Research and Innovation for 2023, 2024 and 2025. Thanks to this agreement, our French partners can benefit from a tax refund on contractual services used for Research and Development activities.

Contact us for more information, our scientific team is available to help you with your projects.